Fennec Pharmaceuticals (FRX) News Today → HUGE BUY ALERT: Move Fast, Musk... (From Stansberry Research) (Ad) Free FRX Stock Alerts C$10.02 -3.70 (-26.97%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 6:52 PM | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low at $9.00Fennec Pharmaceuticals (TSE:FRX) Hits New 12-Month Low at $9.00May 14 at 5:59 PM | finanznachrichten.deFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 12 at 2:44 AM | americanbankingnews.comFennec Pharmaceuticals (FRX) to Release Earnings on TuesdayMay 8, 2024 | marketbeat.comFennec Pharmaceuticals (FRX) to Release Quarterly Earnings on TuesdayFennec Pharmaceuticals (TSE:FRX) will be releasing earnings before the market opens on Tuesday, May 14, Zacks reports.May 6, 2024 | americanbankingnews.comCapital One Financial Equities Analysts Boost Earnings Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX)April 24, 2024 | insidertrades.comAdrian J. Haigh Sells 22,223 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockApril 17, 2024 | insidertrades.comFennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Adrian J. Haigh Acquires 22,222 SharesApril 16, 2024 | marketbeat.comAdrian J. Haigh Buys 22,222 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Senior Officer Adrian J. Haigh purchased 22,222 shares of the firm's stock in a transaction that occurred on Monday, April 15th. The stock was bought at an average cost of C$2.31 per share, for a total transaction of C$51,332.82.April 5, 2024 | finance.yahoo.comInsider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)April 1, 2024 | seekingalpha.comFRX:CA Fennec Pharmaceuticals Inc.March 31, 2024 | insidertrades.comChris Anigeron Rallis Sells 2,114 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockMarch 23, 2024 | seekingalpha.comFennec Pharmaceuticals Inc. (FENC) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | finance.yahoo.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | marketbeat.comWedbush Comments on Fennec Pharmaceuticals Inc.'s Q3 2024 Earnings (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at Wedbush decreased their Q3 2024 earnings per share estimates for Fennec Pharmaceuticals in a research report issued on Thursday, March 21st. Wedbush analyst D. Nierengarten now expects that the biopharmaceutical company wiMarch 21, 2024 | finanznachrichten.deFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateMarch 20, 2024 | marketbeat.comWedbush Research Analysts Cut Earnings Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at Wedbush dropped their FY2024 EPS estimates for Fennec Pharmaceuticals in a research note issued to investors on Monday, March 18th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will poMarch 19, 2024 | ca.finance.yahoo.comStocks in play: Fennec Pharmaceuticals Inc.March 19, 2024 | marketbeat.comFennec Pharmaceuticals Inc. to Post Q2 2024 Earnings of $0.12 Per Share, Wedbush Forecasts (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at Wedbush cut their Q2 2024 earnings per share estimates for Fennec Pharmaceuticals in a research report issued to clients and investors on Monday, March 18th. Wedbush analyst D. Nierengarten now anticipates that the biopharMarch 17, 2024 | markets.businessinsider.comFennec, Norgine Reach Licensing Deal To Commercialize Pedmarqsi In Europe, Australia, & New ZealandFebruary 29, 2024 | finance.yahoo.comFennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsFebruary 23, 2024 | finance.yahoo.comFENC Mar 2024 10.000 callFebruary 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Societal CDMO (SCTL)December 6, 2023 | finance.yahoo.comWith 31% stake, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) seems to have captured hedge funds investors' interestDecember 1, 2023 | morningstar.comFennec Pharmaceuticals Inc FRXNovember 9, 2023 | seekingalpha.comFennec Pharmaceuticals Expands Possible TAM SignificantlyNovember 9, 2023 | finance.yahoo.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesNovember 7, 2023 | finance.yahoo.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call TranscriptNovember 7, 2023 | finance.yahoo.comQ3 2023 Fennec Pharmaceuticals Inc Earnings CallNovember 3, 2023 | benzinga.comPreview: Fennec Pharmaceuticals's EarningsNovember 1, 2023 | finance.yahoo.comInvestors in Fennec Pharmaceuticals (NASDAQ:FENC) have unfortunately lost 20% over the last yearOctober 30, 2023 | finance.yahoo.comFennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023October 5, 2023 | finance.yahoo.comAnalysts Expect Breakeven For Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Before LongSeptember 30, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc up on Friday (FRX)August 23, 2023 | theglobeandmail.comFennec Pharmaceuticals: Top 10 Undervalued Healthcare Sector Stocks on TSX (FRX)May 25, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc down on Wednesday (FRX)May 18, 2023 | bizjournals.comFennec nears European approval for its lead drugMay 16, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc up on Monday (FRX)May 8, 2023 | finance.yahoo.comFennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023May 4, 2023 | finance.yahoo.comFennec Pharmaceuticals Inc. (FRX.TO)May 3, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc up on Tuesday (FRX)May 2, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc flat on Monday (FRX)April 28, 2023 | finance.yahoo.comWhen Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Become Profitable?April 26, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc down on Monday (FRX)April 21, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc flat on Thursday (FRX)April 20, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc down on Tuesday (FRX)April 19, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc flat on Friday (FRX)April 15, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc down on Friday (FRX)April 13, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc down on Thursday (FRX)April 7, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc up on Thursday (FRX)April 6, 2023 | theglobeandmail.comClosing Bell: Fennec Pharmaceuticals Inc up on Wednesday (FRX) Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… FRX Media Mentions By Week FRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FRX News Sentiment▼0.650.57▲Average Medical News Sentiment FRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FRX Articles This Week▼30▲FRX Articles Average Week Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MDNA News Today ONC News Today SVA News Today KSI News Today CARE News Today OPS News Today VMD News Today VHI News Today DR News Today OGI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:FRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
